Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-11-3
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0761-8417
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1329178-Antineoplastic Agents,
pubmed-meshheading:1329178-Carcinoma, Bronchogenic,
pubmed-meshheading:1329178-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:1329178-Chemotherapy, Adjuvant,
pubmed-meshheading:1329178-Humans,
pubmed-meshheading:1329178-Lung Neoplasms,
pubmed-meshheading:1329178-Neoplasm Staging,
pubmed-meshheading:1329178-Randomized Controlled Trials as Topic
|
pubmed:year |
1992
|
pubmed:articleTitle |
[A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
|
pubmed:publicationType |
Editorial,
Review
|